Oxygenta Pharmaceutical Ltd. engages in the development and manufacture of bulk drugs. The company is headquartered in Hyderabad, Telangana. The firm is in the business of manufacture of all classes and kinds of drugs, including pharmaceutical preparation, and organic fine chemicals. The firm is engaged in the manufacture of anti-ulcer drugs and anti-bacterial drugs. The firm is engaged in doing contract manufacturing work for Aurobindo Pharma Limited (APL) and also has its own production. The firm has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from Fluoro Chloro Quinolonic acid (Q-Acid). The firm is manufacturing Pantaprozole Sodium and Gabapentine for own production. The firm's plant is situated at Survey No. 252/1, Aroor Village, Sadasivapet Mandal, Medak District, Telangana.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
18 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.